A naukri.com initiative
Bioengineer
2d
241
Image Credit: Bioengineer
Dr. Jeremy L. Davis Appointed UMGCCC Surgical Oncology Lead and Chief of Surgical Oncology Division at UMSOM
- Renowned surgical oncologist Dr. Jeremy L. Davis appointed as the new Surgical Oncology Lead and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM.
- Dr. Davis is celebrated for his pioneering research in hereditary gastric cancer and his extensive experience and prolific track record made him a standout candidate from a highly competitive nationwide search aimed at identifying an exceptional leader for the Division of Surgical Oncology.
- As UMGCCC seeks to enhance its clinical and research capabilities in oncology, particularly in the realm of gastric cancer, where Dr. Davis has already made substantial contributions, his appointment reflects UMGCCC’s commitment to building a robust framework for cancer research and patient care.
- Dr. Davis’s appointment represents a pivotal moment not just for UMGCCC but for the landscape of surgical oncology as a whole.
- One of the cornerstones of Dr. Davis’s research focus has been the examination of the CDH1 tumor suppressor gene, which is implicated in diffuse gastric cancer and lobular breast cancer. His work on understanding the molecular mechanisms driving these cancers not only enhances our comprehension of hereditary breast and gastric cancers but also opens doors for innovative treatment strategies.
- Dr. Taofeek K. Owonikoko, Executive Director of UMGCCC, expressed enthusiastic support for Dr. Davis, highlighting his impressive clinical credentials and groundbreaking research.
- Dr. Davis’s academic journey began with a Doctor of Medicine degree from the University of South Florida College of Medicine. He then completed a demanding general surgery residency at Indiana University School of Medicine, during which he engaged in additional research and fellowship training focused on surgical oncology at the NCI.
- With an h-index of 30 and over 100 peer-reviewed publications to his credit, Dr. Davis’s scholarly contributions are noteworthy within the medical community.
- The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has a long-standing reputation for its comprehensive approach to cancer treatment, incorporating a blend of clinical care, cutting-edge research, and community outreach.
- Under Dr. Davis's leadership, there is a palpable sense of optimism regarding the potential advancements in cancer care and research that will emanate from UMGCCC under his tutelage.
Read Full Article
14 Likes
For uninterrupted reading, download the app